Bridging antimicrobial resistance knowledge gaps: The East African perspective on a global problem

• DOI: 10.1371/journal.pone.0212131
• Publication Date: 2019-02-11T13:39:54Z
• Authors: Frederick K. Wangai; Moses M. Masika; Godfrey N. Lule; Emma M. Karari; Marybeth C. Maritim; Walter G. Jaoko; Beatrice Museve; Antony Kuria
• Keywords: Male; Methicillin-Resistant Staphylococcus aureus; 0301 basic medicine; Health Knowledge, Attitudes, Practice; Science; Microbial Sensitivity Tests; Global Health; Tertiary Care Centers; Antimicrobial Stewardship; 03 medical and health sciences; Drug Resistance, Bacterial; Escherichia coli; Humans; Retrospective Studies; Q; R; Africa, Eastern; Kenya; 3. Good health; Klebsiella pneumoniae; Pseudomonas aeruginosa; Medicine; Female; Needs Assessment; Research Article

There is worldwide concern of rapidly increasing antimicrobial resistance (AMR). However, there is paucity of resistance surveillance data and updated antibiograms in Africa in general. This study was undertaken in Kenyatta National Hospital (KNH) -the largest public tertiary referral centre in East & Central Africa-to help bridge existing AMR knowledge and practice gaps.A retrospective review of VITEK 2 (bioMérieux) records capturing antimicrobial susceptibility data for the year 2015 was done and analysed using WHONET and SPSS.Analysis of 624 isolates revealed AMR rates higher than most recent local and international reports. 88% of isolates tested were multi-drug resistant (MDR) whereas 26% were extensively-drug resistant (XDR). E. coli and K. pneumoniae had poor susceptibility to penicillins (8-48%), cephalosporins (16-43%), monobactams (17-29%), fluoroquinolones (22-44%) and trimethoprim-sulfamethoxazole (7%). Pseudomonas aeruginosa and Acinetobacter baumanii were resistant to penicillins and cephalosporins, with reduced susceptibility to carbapenems (70% and 27% respectively). S aureus had poor susceptibility to penicillins (3%) and trimethoprim-sulfamethoxazole (29%) but showed excellent susceptibility to imipenem (90%), vancomycin (97%) and linezolid (99%).The overwhelming resistance to commonly used antibiotics heralds a clarion call towards strengthening antimicrobial stewardship programmes and regular AMR regional surveillance.